Page 2 - Full Fact Sheet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Full Fact Sheet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Full Fact Sheet Today - Breaking & Trending Today

EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

Published: December 9, 2021

09.12.2021 - AstraZeneca's EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses ...

Source: wallstreet-online.de

Related Topics:

United StatesUnited KingdomBrian KoffmanMyronj LevinNational Institute Of HealthVanderbilt University Medical CenterDepartment Of DefenseDepartment Of HealthUniversity Of Colorado School MedicineNuclear DefenseCenters For DiseaseNational CenterBiomedical Advanced ResearchHuman ServicesDrug AdministrationProgram Executive Office For ChemicalDevelopment AuthorityTranslational Sciences Open Data PortalChronic Lymphocytic Leukemia SocietyOffice Of TheBusiness WireColorado SchoolExecutive Vice PresidentChief Medical OfficerChronic Lymphocytic Leukemia